SCHEMBL769660

SCHEMBL769660

CC(=O)C1(C(=O)O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11986245 0.88 FFAR3 (0.39)
SCHEMBL10586224 0.88 FFAR3 (0.39)
SCHEMBL13736831 0.86 CYP2C19 (0.39)
SCHEMBL762293 0.83
SCHEMBL7406547 0.82 KDM4E (0.38)
SCHEMBL17049038 0.80 MEN1 (0.34)
SCHEMBL106415 0.79
SCHEMBL8641820 0.79 FFAR3 (0.44)
SCHEMBL18215019 0.78 USP2 (0.43)
SCHEMBL8950435 0.78 LMNA (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115160116-B Preparation method of cyclopropyl methyl ketone 北京航天试验技术研究所 2024-01-26 CN claimed
US-12617762-B2 Carboxy derivatives with antiinflamatory properties SITRYX THERAPEUTICS LIMITED (GB) 2026-05-05 US disclosed
EP-4081511-B3 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES SITRYX THERAPEUTICS LTD (GB) 2026-03-04 EP disclosed
EP-4442319-A2 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES Sitryx Therapeutics Limited (GB) 2024-10-09 EP disclosed
EP-4081511-B1 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES SITRYX THERAPEUTICS LTD (GB) 2024-07-31 EP disclosed
CN-115160116-B Preparation method of cyclopropyl methyl ketone 北京航天试验技术研究所 2024-01-26 CN disclosed
CN-115160116-B Preparation method of cyclopropyl methyl ketone 北京航天试验技术研究所 2024-01-26 CN disclosed
US-20230399287-A1 NOVEL COMPOUNDS SITRYX THERAPEUTICS LIMITED (GB) 2023-12-14 US disclosed
US-20230399285-A1 ILLUDIN ANALOGS, USES THEREOF, AND METHODS FOR SYNTHESIZING THE SAME LANTERN PHARMA INC. (US) 2023-12-14 US disclosed
US-20230399285-A1 ILLUDIN ANALOGS, USES THEREOF, AND METHODS FOR SYNTHESIZING THE SAME LANTERN PHARMA INC. (US) 2023-12-14 US disclosed
US-5977133-A Pyridone antibiotic with improved safety profile ABBOTT LABORATORIES (US) 1999-11-02 US disclosed
CN-1036193-C Preparation of a sprio compound DAIICHI SEIYAKU CO (JP) 1997-10-22 CN disclosed
US-5508428-A Spiro compound DAIICHI PHAMACEUTICAL CO., LTD. (JP) 1996-04-16 US disclosed
CN-1028102-C Preparation of spiro compounds DAIICHI SEIYAKU CO (JP) 1995-04-05 CN disclosed
CN-1100095-A Preparation of a sprio compound DAIICHI SEIYAKU CO (JP) 1995-03-15 CN disclosed
US-5286723-A Spiro compound DAIICHI SEIYAKU CO., LTD. 1994-02-15 US disclosed
EP-0357047-B1 Spiro compounds DAIICHI SEIYAKU CO (JP) 1993-11-03 EP disclosed
EP-0529688-A2 Azaspiro n,m alkanes and diazaspiro n,m -alkanes DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1993-03-03 EP disclosed
CN-1040790-A Preparation of spiro compounds DAIICHI SEIYAKU CO (JP) 1990-03-28 CN disclosed
EP-0357047-A1 Spiro compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1990-03-07 EP disclosed